BASF Ingredient Suffers Identity Crisis In FDA Review
This article was originally published in The Tan Sheet
Executive Summary
FDA says BASF must clarify whether tests studied bisoctrizole or the firm’s compound marketed as Tinosorb M, which combines bisoctrizole and other ingredients.